Edwards Lifesciences Corp stock forecast 2012

Edwards Lifesciences Corp stock forecast 2012 ; Edwards Lifesciences (EW +0.12%) is the world's largest creator of artificial heart valves, including valves made from animal tissue and annuloplasty rings that repair damaged valves.

Recently, the company received FDA approval to sell the Sapien Heart valve, the first transcatheter valve sold in a U.S. market.

Thanks to this one product, EW expects $20 million to $25 million in additional revenue for Q1 2012 and $150 million to $250 million in the first full year. This is a tremendous development and I expect that it will be a strong year ahead for EW shares.For the latest updates on the stock market, visit Stock Market Today For the latest updates PRESS CTR + D or visit Stock Market news Today

Related Post: